Clinical trials: Oncologic Patients
Clostridium Difficile Infection, Hematologic Diseases
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
This study will randomized hematology oncology patients with active diarrhea and a NAAT positive/toxin EIA negative to either 14 days of oral vancomycin capsules or placebo.
- Conditions
- Clostridium Difficile Infection, Hematologic Diseases, Bone Marrow Transplant, Oncologic Disorders
- Trial name
- NCT03030248
- Testing
- Vancomycin Oral Capsule
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- Medical College of Wisconsin
Acceptance and Commitment Therapy
Investigation of the Effect of Acceptance and Commitment Therapy-Based Intervention in Oncology Patients
The goal of this clinical trial is to investigate the effectiveness of Acceptance and Commitment Therapy Based Intervention for Oncology Patients.
- Trial name
- NCT06457178
- Testing
- Acceptance and Commitment Therapy-Based Intervention for Oncology Patients, Psychoeducation for Oncology Patients
- Where
- Turkey (Türkiye)
- Volunteers
- 75 people
- Sponsor
- Istanbul University - Cerrahpasa
Neoplasms
Evaluating the Impact of Patient-Centered Oncology Care
The National Committee for Quality Assurance has worked with the National Coalition for Cancer Survivorship, the American Society of Clinical Oncology, Oncology Management Services, Independence Blue Cross, and RAND, as well as a…
- Trial name
- NCT02110758
- Testing
- Pilot of Patient-Centered Oncology Care
- Where
- United States
- Volunteers
- 125,250 people
- Sponsor
- National Committee for Quality Assurance
Neoplasms, Gynaecological Oncology
Impact of Pharmacy Services on Gynaecology Chemotherapy Safety
What was studied? We wanted to see whether having pharmacists closely involved in cancer care improves medication safety and reduces severe side effects for patients with gynecologic cancers (like ovarian or uterine cancer)…
- Trial name
- NCT06826950
- Testing
- comprehensive pharmaceutical care, Routine pharmaceutical services
- Where
- China
- Volunteers
- 629 people
- Sponsor
- Peking University First Hospital
Astrocytoma, IDH-Mutant, Glioblastoma
Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
This phase IV trial compares patient satisfaction with telehealth versus in-person neuro-oncology assessments among glioma patients receiving oral chemotherapy.
- Conditions
- Astrocytoma, IDH-Mutant, Glioblastoma, Glioma, Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
- Trial name
- NCT06625047
- Testing
- Assessment, Questionnaire Administration, Telemedicine Visit
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Mayo Clinic
Breast Cancer
Effects of an ICT-platform for Assessment and Management of Patient-reported Symptoms During Treatment for Breast Cancer
The purpose of this study is to evaluate the effects of an interactive Information and Communication Technologies (ICT) -platform for use in a smartphone or tablet in patients treated with neoadjuvant chemotherapy for breast…
- Trial name
- PhONEME (NCT02479607)
- Testing
- Smartphone or tablet
- Where
- Sweden
- Volunteers
- 150 people
- Sponsor
- Karolinska Institutet
Metastatic Urothelial Carcinoma
Urine Omics Predicting IO Therapy Responses in mUC Patients
The study aims to identify urinary metabolite and protein markers that can predict anti-tumor efficacy and adverse events in subjects receiving IO-based therapies for metastatic urothelial carcinoma.
- Trial name
- NCT04641936
- Testing
- No intervention required
- Where
- Taiwan
- Volunteers
- 600 people
- Sponsor
- National Taiwan University Hospital
Cancer, Mindfulness-based Intervention
Effects of a Second-generation Mindfulness-based Intervention on Quality of Life, Pain Management, and Psycho-spiritual Wellbeing in Cancer Patients: A Randomised Controlled Trial
Background This study explores the effectiveness of Meditation Awareness Training (MAT), a second-generation mindfulness-based intervention, in enhancing quality of life, pain management, and psycho-spiritual wellbeing among…
- Conditions
- Cancer, Mindfulness-based Intervention, Meditation, Psychological Well-Being
- Trial name
- NCT06695234
- Testing
- Meditation Awareness Training
- Where
- United Kingdom
- Volunteers
- 200 people
- Sponsor
- University of Derby
Acute Myeloid Leukemia
Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
This is a Phase 1, multicenter, open-label study to evaluate safety, tolerability and pharmacokinetics of milademetan in Japanese patients with relapsed or refractory acute myeloid leukemia.
- Trial name
- NCT03671564
- Testing
- Milademetan
- Where
- 8 sites in Japan
- Volunteers
- 14 people
- Sponsor
- Daiichi Sankyo Co., Ltd.
Head and Neck Cancer, Advanced Cancer
Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN)
This study aims to study the kinetics of ctDNA levels after the first dose of immune checkpoint inhibitor in patients with recurrent or metastatic head and neck cancer.
- Conditions
- Head and Neck Cancer, Advanced Cancer, Metastatic Cancer, HNSCC
- Trial name
- NCT04606940
- Where
- Canada
- Volunteers
- 18 people
- Sponsor
- University Health Network, Toronto
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Weighted Blanket Use to Reduce Anxiety in Oncology Patients
This clinical trial compares the effect of using weighted blankets versus regular blankets during first time infusions (e.g. chemotherapy, targeted therapy etc.) to decrease adverse side effects such as anxiety and distress in…
- Trial name
- NCT06089408
- Testing
- Best Practice, Supportive Care, Survey Administration
- Where
- United States
- Volunteers
- 114 people
- Sponsor
- Ohio State University Comprehensive Cancer Center
Malignant Solid Neoplasm
Development of a Digital Tool, MyInspiration, for the Improvement of Spiritual Well-Being in Patients with Cancer
The purpose of this study is to pilot a beta version of a digital resource that supports the religious and spiritual beliefs of cancer patients, "MyInspiration".After receiving a cancer diagnosis, survivors are encouraged to make…
- Trial name
- NCT05198089
- Testing
- Internet-Based Intervention
- Where
- United States
- Volunteers
- 52 people
- Sponsor
- Ohio State University Comprehensive Cancer Center
Geriatrics, Medical Oncology
Geriatric and Oncological Evaluation With Technology for Holistic Healthcare Management for Older Multimorbid Patients.
The GerOnTe TWOBE study aims to evaluate the effectiveness of the GerOnTe intervention, consisting of a renewed, patient-centred, care pathway coordinated by an APN and supported by a Health Professional Consortium and IC…
- Conditions
- Geriatrics, Medical Oncology, Critical Pathways, Digital Technology
- Trial name
- GerOnTe-TWOBE (NCT05423808)
- Testing
- Health Professional Consortium, Holis Dashboard - Holis Patient App
- Where
- Belgium
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Elderly
Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
The CARTIER study is a randomized, multicenter, open-label clinical trial comparing, in elderly patients with cancer under anti-tumoral treatment, two different cardiotoxicity prevention strategies: primary (intensive…
- Conditions
- Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Elderly, Antineoplastic Agents, Cardiotoxicity
- Trial name
- CARTIER (NCT03711110)
- Testing
- Intensive cardiovascular monitoring, No intervention
- Where
- 14 sites in Spain
- Volunteers
- 514 people
- Sponsor
- Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Distress, Anxiety
(Cost-)Effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in Cancer Patients
Mindfulness-based cognitive therapy has been demonstrated to be effective in reducing anxiety, depression and fatigue in cancer patients. As this intervention can be offered in groups, costs are relatively low.
- Conditions
- Distress, Anxiety, Depression
- Trial name
- BeMind (NCT02138513)
- Testing
- Mindfulness Based Cognitive Therapy
- Where
- 2 sites in Netherlands
- Volunteers
- 245 people
- Sponsor
- Radboud University Medical Center
Cancer, Solid Tumor
MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer
The purpose of this Expanded Access Program (EAP) is to allow use of the investigational therapeutic agent, MNPR-101-PCTA-177Lu, for treatment of urokinase plasminogen activator receptor (uPAR)-positive solid tumors identified…
- Conditions
- Cancer, Solid Tumor, Solid Tumor Cancer, Oncology
- Trial name
- NCT06980519
- Testing
- MNPR-101-PCTA-177Lu
- Where
- United States
- Sponsor
- Monopar Therapeutics
Malignant Female Reproductive System Neoplasm
Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients
Prophylactic treatment will start from surgery until the patients are discharged from the hospital(18). Then each patient will have 2 follow up visit in gyne- oncology clinic.
- Trial name
- Lovenox (NCT01356329)
- Testing
- Enoxaparin, Heparin
- Where
- Saudi Arabia
- Volunteers
- 150 people
- Sponsor
- National Guard Health Affairs
Acute Lung Injury
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
Acute lung injury (ALI) is a common, life-threatening complication among pediatric leukemia and lymphoma and hematopoietic stem cell transplant (HSCT) recipients.
- Trial name
- CALIPSO (NCT00999713)
- Testing
- Calfactant
- Where
- 16 sites in United States, Canada
- Volunteers
- 43 people
- Sponsor
- Milton S. Hershey Medical Center
Hypertensive Patients
Pharmacometric Modeling of a Hospital Preparation
Pediatric prescribers are very often faced with a lack of suitable therapies, particularly oral ones. This represents a major public health problem and necessitates adjustments to dosage or pharmaceutical form using medications…
- Trial name
- PEDIATENS (NCT07372560)
- Testing
- Evaluation of the pharmacokinetic parameters of an oral formulation of nicardipine hydrochloride
- Where
- France
- Volunteers
- 30 people
- Sponsor
- University Hospital, Rouen
Breast Cancer
PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
The purpose of this trial is to evaluate 2-year disease-free survival in this patient population treated with single agent cisplatin and patients treated with cisplatin in combination with Rucaparib following preoperative…
- Trial name
- NCT01074970
- Testing
- Cisplatin, Rucaparib
- Where
- 27 sites in United States
- Volunteers
- 135 people
- Sponsor
- Hoosier Cancer Research Network
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.